Medications

FDA panel narrowly backs Cempra antibiotic

A panel of federal health advisers has narrowly recommended approval for an experimental antibiotic from Cempra Inc., a small North Carolina drugmaker.

Immunology

Groundbreaking immune approach targets humans instead of bacteria

Staphylococcal and streptococcal infections affect millions of individuals each year. They are a leading cause of sepsis and account for many cases of pneumonia and post-surgical infections. Despite the urgency of this situation, ...

Diseases, Conditions, Syndromes

Antimicrobial resistance to carbapenems increasing

(HealthDay)—Antimicrobial resistance to carbapenems has increased, and consumption of antibiotics, especially carbapenems, is associated with antimicrobial resistance of Pseudomonas aeruginosa, according to a study published ...

Medical research

A new angle for countering severe bacterial infections and sepsis

Bacterial infections that don't respond to antibiotics are of rising concern, as is sepsis—the immune system's last-ditch, failed attack on infection that ends up being lethal itself. Reporting online in Nature on July ...

page 9 from 17